Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Adherence and associated sociodemographic and clinical factors in patients with metastatic breast cancer treated with CDK 4/6 inhibitors (CROSBI ID 725027)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija

Krajinović, Magdalena ; Benić, Lucija ; Baković, Matea ; Ortner Hadžiabdić, Maja ; Silovski, Tajana ; Dedić Plavetić , Natalija ; Sertić, Miranda Adherence and associated sociodemographic and clinical factors in patients with metastatic breast cancer treated with CDK 4/6 inhibitors // Knjiga sažetaka FIP World Congress of Pharmacy and Pharmaceutical Sciences 2022, International Pharmaceutical Federation, 2022. Sevilla, 2022. str. \-\

Podaci o odgovornosti

Krajinović, Magdalena ; Benić, Lucija ; Baković, Matea ; Ortner Hadžiabdić, Maja ; Silovski, Tajana ; Dedić Plavetić , Natalija ; Sertić, Miranda

engleski

Adherence and associated sociodemographic and clinical factors in patients with metastatic breast cancer treated with CDK 4/6 inhibitors

Evaluation of adherence and associated sociodemographic and clinical factors in patients with metastatic breast cancer treated with CDK 4/6 inhibitors

adherence ; metastatic breast cancer ; CDK 4/6 inhibitors

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

\-\.

2022.

objavljeno

Podaci o matičnoj publikaciji

Podaci o skupu

80th FIP World Congress of Pharmacy and Pharmaceutical Sciences (FIP Seville 2022)

poster

18.09.2022-22.09.2022

Sevilla, Španjolska

Povezanost rada

Farmacija, Kliničke medicinske znanosti